hotspot -WSS

hotspot

author：hotspot 2025-10-04 08:21:54 - browse：7463

Electrocardiogram in the shape of the United States map — Adobe

The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But it is often difficult to compare them head to head with similar products, or tell whether they will work on different kinds of patients.

A new company is promising to change that — if it can convince AI developers to expose their products to more rigorous testing.

Called Dandelion Health, the New York-based firm is launching a first-of-its-kind public service to evaluate AI products on independent data designed to root out weaknesses and reveal bias. The company said Wednesday its initial pilot program, to begin next month, will focus on testing algorithms that use electrocardiograms to predict heart conditions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Democratic lawmaker calls for 'well

WSS

Boston competes with Raleigh

New clues to why women have higher risk of autoimmune disorders

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Pancreatic cancer early detection could be helped by AI

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Investment in vaccine development is lagging, report finds

explore

hotspot

knowledge

Jerome Adams on the need for new antivirals for Covid

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Peter Hotez and the public health issue of online harassment

Pancreatic cancer early detection could be helped by AI

Virginia high school admissions case could be legal follow

Democratic lawmaker calls for 'well

Trump demands the U.S. pay no more for drugs than other countries … again

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Trump demands the U.S. pay no more for drugs than other countries … again

Democratic lawmaker calls for 'well

leisure time

Medicare drug price negotiation legal challenge met with skepticism

FTC sues over Novant Health acquisition of two N.C. hospitals

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Medicare drug price negotiation legal challenge met with skepticism

'The Exorcist' director William Friedkin dead at 87

knowledge

hotspot

Wikipedia

explore